Insulet (FRA:GOV) Accounts Payable & Accrued Expense : €239 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Insulet Accounts Payable & Accrued Expense?

Insulet's quarterly accounts payable & accrued expense declined from Sep. 2023 (€239 Mil) to Dec. 2023 (€193 Mil) but then increased from Dec. 2023 (€193 Mil) to Mar. 2024 (€239 Mil).

Insulet's annual accounts payable & accrued expense increased from Dec. 2021 (€116 Mil) to Dec. 2022 (€180 Mil) and increased from Dec. 2022 (€180 Mil) to Dec. 2023 (€193 Mil).

Insulet Accounts Payable & Accrued Expense Historical Data

The historical data trend for Insulet's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet Accounts Payable & Accrued Expense Chart

Insulet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

100.71

114.34

115.94

179.93

193.49

Insulet Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															226.68	232.14	239.50	193.49	239.38

Insulet Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Insulet (FRA:GOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

PODD:USA PODD:Mexico

Address

100 Nagog Park, Acton, MA, USA, 01720

Website

https://www.insulet.com

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.

Insulet (FRA:GOV) Headlines

No Headlines